Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease.

Ibrahim Sandokji, Yunwen Xu, Michelle Denburg, Susan Furth, Alison G Abraham, Jason H Greenberg

Nephron 2024

filter terms:

Due to the complexity of chronic kidney disease (CKD) pathophysiology, biomarkers representing different mechanistic pathways have been targeted for the study and development of novel biomarkers. The discovery of clinically useful CKD biomarkers would allow for the identification of those children at the highest risk of kidney function decline for timely interventions and enrollment in clinical trials. Glomerular filtration rate and proteinuria are traditional biomarkers to classify and prognosticate CKD progression in clinical practice but have several limitations. Over the recent decades, novel biomarkers have been identified from blood or urine with metabolomic screening studies, proteomic screening studies, and an improved knowledge of CKD pathophysiology. This review highlights promising biomarkers associated with the progression of CKD that could potentially serve as future prognostic markers in children with CKD. Further studies are needed in children with CKD to validate putative biomarkers, particularly candidate proteins and metabolites, for improving clinical management. © 2023 S. Karger AG, Basel.

Citation

Ibrahim Sandokji, Yunwen Xu, Michelle Denburg, Susan Furth, Alison G Abraham, Jason H Greenberg. Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease. Nephron. 2024;148(1):1-10